ELMD
Get informed when a big investor buys or sells
+ FollowUndervalued by 51.8% based on the discounted cash flow analysis.
| Market cap | $225.63 Million |
|---|---|
| Enterprise Value | $205.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.37 |
| Beta | 0.46 |
| Outstanding Shares | 8,266,071 |
| P/E Ratio | 19.89 |
|---|---|
| PEG | 36.62 |
| Price to Sales | 3.3 |
| Price to Book Ratio | 4.4 |
| Enterprise Value to Revenue | 2.78 |
| Enterprise Value to EBIT | 14.65 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 5,500▼ 73.17% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 56.38%▲ 1.91% |
|---|---|
| Total Invested | $197.14M▲ 88.21% |
| Investors Holding | 131▲ 27.00% |
No data
Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.